These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 29466411)

  • 1. Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case.
    Gautam SS; Mac Aogáin M; Cooley LA; Haug G; Fyfe JA; Globan M; O'Toole RF
    PLoS One; 2018; 13(2):e0192351. PubMed ID: 29466411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversified lineages and drug-resistance profiles of clinical isolates of
    Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
    Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis Complex Drug Resistance in a High Tuberculosis Incidence Area from the WHO Eastern Mediterranean Region.
    Mansoori N; Douraghi M; Rajabloo AA; Taziki M; Yaseri M; Vaziri F
    J Pharm Pharm Sci; 2017; 20(1):428-434. PubMed ID: 29197427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].
    Wang JJ; Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1189-93. PubMed ID: 20193593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2008 and 2009. A report of the Australian Mycobacterium Reference Laboratory Network.
    Lumb R; Bastion I; Carter R; Jelfs P; Keehner T; Sievers A
    Commun Dis Intell Q Rep; 2011 Jun; 35(2):154-61. PubMed ID: 22010508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
    Melzer M; Gupta N; Petersen I; Cook S; Hall B
    Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Mai TQ; Martinez E; Menon R; Van Anh NT; Hien NT; Marais BJ; Sintchenko V
    Am J Trop Med Hyg; 2018 Dec; 99(6):1397-1406. PubMed ID: 30382014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs.
    Gurjav U; Erkhembayar B; Burneebaatar B; Narmandakh E; Tumenbayar O; Hill-Cawthorne GA; Marais BJ; Sintchenko V
    Tuberculosis (Edinb); 2016 Dec; 101():49-53. PubMed ID: 27865397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic, phenotypic and demographic characterization of
    Losev Y; Rubinstein M; Nissan I; Haviv P; Barsky Y; Volinsky M; Bar-Giora G; Zouher T; Hamawi M; Valenci GZ; Kutikov I; Shwartz HK; Dveyrin Z; Chemtob D; Rorman E
    Front Cell Infect Microbiol; 2023; 13():1196904. PubMed ID: 37928179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of Mycobacterium tuberculosis drug susceptibility testing and genotyping with epidemiological data analysis to gain insight into the epidemiology of drug-resistant tuberculosis in Malatya, Turkey.
    Agarwal M; Gunal S; Durmaz R; Yang Z
    J Clin Microbiol; 2010 Sep; 48(9):3301-5. PubMed ID: 20660214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low antimicrobial resistance rates of Mycobacterium tuberculosis complex between 2000 and 2015 in Gipuzkoa, northern Spain.
    Vicente D; Basterretxea M; de la Caba I; Sancho R; López-Olaizola M; Cilla G
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Nov; 37(9):574-579. PubMed ID: 30850232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
    Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
    BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices.
    Joean O; Thiele T; Schütz K; Schwerk N; Sedlacek L; Kalsdorf B; Baumann U; Stoll M
    BMC Infect Dis; 2020 Sep; 20(1):678. PubMed ID: 32942990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.
    Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN
    Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status.
    Wollenberg K; Harris M; Gabrielian A; Ciobanu N; Chesov D; Long A; Taaffe J; Hurt D; Rosenthal A; Tartakovsky M; Crudu V
    BMC Infect Dis; 2020 Jan; 20(1):17. PubMed ID: 31910804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2005.
    Lumb R; Bastian I; Gilpin C; Jelfs P; Keehner T; Sievers A;
    Commun Dis Intell Q Rep; 2007 Mar; 31(1):80-6. PubMed ID: 17503647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.